Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

K Wilcock, G; Lilienfeld, Sean; Gaens, E.

doi:10.1136/bmj.321.7274.1445

Public

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

Published in BMJ • Dec 9, 2000

Authors:

G K Wilcock

Sean Lilienfeld

E. Gaens

Abstract

OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer's disease...

Subject

Galantamine

Placebo

Dementia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!